Pharmaxis Announces Delay to French Pricing for Bronchitol
29th
Aug 13
Release Date: 29/08/2013 12:00am
Pharmaceutical company Pharmaxis (ASX:PXS) today announced it will scale back resources and investments dedicated to the launch of Bronchitol in France due to delays in reaching an agreement with French authorities on a reimbursed price for the cystic fibrosis treatment.
Categories: News and Media